Artelo to advance NEOMED's NEO1940 novel, peripherally restricted, CB1/CB2 agonist, clinic-ready drug candidate for the treatment of patients suffering from cancer and anorexia/weight loss associated with cancer
La Jolla, CA, USA / Montreal, QC, Canada - January 30, 2018